Medscape |
Most New Cancer Drugs Don't Improve Survival or QoL
Medscape The majority of new oncology drugs that were approved by the European Medicines Agency (EMA) from 2009 to 2013 entered the market without clear evidence that they improved survival or quality of life, according to a new report published online October ... Cancer patients need more than survival Study Questions European Approval Process for Cancer Drugs Many new cancer drugs show 'no clear benefit', argues review |
from Health - Google News http://ift.tt/2wzMZSP
EmoticonEmoticon